| abstract |
The present invention relates to bispecific antibodies against human VEGF and human ANG-2, methods for producing them, pharmaceutical compositions containing the antibodies, and their provision and use. A first antigen-binding site that specifically binds to human VEGF and human angio which specifically binds to human vascular endothelial growth factor (VEGF) and human angiopoietin 2 (ANG-2) A bispecific antibody comprising a second antigen binding site that specifically binds to poetin 2 (ANG-2). [Selection figure] None |